Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer

Saved in:

Bibliographic Details
Main Authors:	Valette,Thiago N., Antunes,Alberto A., Leite,Kátia Moreira, Srougi,Miguel
Format:	Digital revista
Language:	English
Published:	Sociedade Brasileira de Urologia 2015
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382015000300449
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Well-differentiated prostate cancer in core biopsy specimens may be associated with extraprostatic disease
by: Cury,José, et al.
Published: (2008)

Prognostic value of the percentage of positive fragments in biopsies from patients with localized prostate cancer
by: Antunes,Alberto A., et al.
Published: (2005)

Prediction of pathological stage in prostate cancer through the percentage of involved fragments upon biopsy
by: Dall'oglio,Marcos F., et al.
Published: (2005)

Prostate biopsy: is age important for determining the pathological features in prostate cancer?
by: Antunes,Alberto A., et al.
Published: (2005)

The role of extended prostate biopsy on prostate cancer detection rate: a study performed on the bench
by: Nesrallah,Luciano, et al.
Published: (2008)

The percentage of affected fragments in needle biopsy in the assessment of pathological staging of prostate cancer
by: Andrade,Rógerson Tenorio de, et al.
Published: (2013)

Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatectomy?
by: Silva,Ricardo Kupka da, et al.
Published: (2013)

Is the positive biopsy core percent really predictive of non-organ confined prostate carcinoma?
by: Önol,Fikret Fatih, et al.
Published: (2005)

Retrospective study comparing six - and twelve-core prostate biopsy in detection of prostate cancer
by: Tobiume,Motoi, et al.
Published: (2008)

Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy
by: Prando,Adilson
Published: (2010)

Pathological extension of prostate cancer as defined by gleason score on biopsy
by: Dall'oglio,Marcos F., et al.
Published: (2005)

Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments
by: Antunes,Alberto A., et al.
Published: (2007)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Porcaro,Antonio B., et al.
Published: (2020)

Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy
by: Leite,Katia Ramos Moreira, et al.
Published: (2008)

PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
by: Antunes,Alberto A., et al.
Published: (2013)

The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia
by: Nomikos,Michael, et al.
Published: (2011)

Re: PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples
by: Antunes,Alberto A., et al.
Published: (2014)

Clinical utility of prostate-specific antigen mass ratio for prediction of prostate cancer detection on a repeated prostate biopsy
by: Lee,Won Ki, et al.
Published: (2014)

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy
by: Chambó,Renato Caretta, et al.
Published: (2015)

Predictive criteria of insignificant prostate cancer: what is the correspondence of linear extent to percentage of cancer in a single core?
by: Billis,Athanase, et al.
Published: (2015)

Histopathological findings in extended prostate biopsy with PSA ≤ 4 ng/mL
by: Leite,Katia R., et al.
Published: (2008)

Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer
by: Konyalioglu,Ersin, et al.
Published: (2015)

Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin
by: Vasudeva,Pawan, et al.
Published: (2015)

Influence of focal and diffuse extraprostatic extension and positive surgical margins on biochemical progression following radical prostatectomy
by: Billis,Athanase, et al.
Published: (2012)

Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy
by: Oh,Jin Kyu, et al.
Published: (2012)

Quantification of tumor extension in prostate biopsies: importance in the identification of confined tumors
by: Leite,Kátia R.M., et al.
Published: (2003)

Repeat prostate biopsies following diagnoses of prostate intraepithelial neoplasia and atypical small gland proliferation
by: Leite,Katia R., et al.
Published: (2005)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Balaban,Muhsin, et al.
Published: (2020)

Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology
by: Fajardo,DA, et al.
Published: (2011)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
by: Uçer,Oktay, et al.
Published: (2015)

Editorial Comment: Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Diniz,Andre Luiz Lima
Published: (2020)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Porpiglia,Francesco, et al.
Published: (2015)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pepe,Pietro, et al.
Published: (2015)

Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy
by: Antunes,Alberto A., et al.
Published: (2006)

Preparation and management of complications in prostate biopsies
by: Tyng,Chiang Jeng, et al.
Published: (2013)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Fiamegos,Alexandros, et al.
Published: (2016)

Antibiotic prophylaxis in prostate biopsy: a comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol
by: Tobias-Machado,M, et al.
Published: (2003)

Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?
by: Billis,Athanase, et al.
Published: (2007)

Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer
by: Cohen,Jacob H., et al.
Published: (2010)

Can expressed prostatic secretions affect prostate biopsy decision of urologist?
by: Ergün,Osman, et al.
Published: (2019)

Resource Map